Oct 26, 2023 / 09:30PM GMT
Mark Wilterding - Edwards Lifesciences Corporation - VP of IR
Well, thanks, everyone, for joining us. I know it's been a busy week. We're really glad that you stuck around for this event on Thursday. We're excited for you to be here, both in person and online. We've got a great panel set up, an opportunity for you to ask questions on what you heard earlier this morning on our TMTT data, which was really exciting for us.
Before we get into it, I'm going to flash up the quick cautionary statement here that I showed yesterday as well. Please take a minute to familiarize yourself with it, if you haven't already. It's available on our website as well.
In terms of the layout of today's event, I'm going to ask Bernard Zovighian, our CEO, to come up and make some quick introductory remarks. And then we'll turn it over to the panel for an in-depth Q&A session, again, on the TMTT data that you saw this morning. So with that, let me welcome Bernard Zovighian to the stage.
Bernard J. Zovighian - Edwards Lifesciences Corporation - CEO & Director
Edwards Lifesciences Corp Investor and Analyst TMTT Q&A Session at TCT Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers